{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:04:08Z","timestamp":1757617448679,"version":"3.44.0"},"reference-count":44,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.2169\/internalmedicine.4832-24","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:14:41Z","timestamp":1741976081000},"page":"2619-2625","source":"Crossref","is-referenced-by-count":0,"title":["Immunoglobulin A Nephropathy in a Kidney Transplant Recipient with Kabuki Syndrome"],"prefix":"10.2169","volume":"64","author":[{"given":"Takahiro","family":"Shinzato","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuichi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Okawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Niikawa N, Kuroki Y, Kajii T, et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet 31: 565-589, 1988.","DOI":"10.1002\/ajmg.1320310312"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. B\u00f6gershausen N, Gatinois V, Riehmer V, et al. Mutation update for Kabuki syndrome genes <i>KMT2D<\/i> and <i>KDM6A<\/i> and further delineation of X-linked Kabuki syndrome subtype 2. Hum Mutat 37: 847-864, 2016.","DOI":"10.1002\/humu.23026"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Digilio MC, Gnazzo M, Lepri F, et al. Congenital heart defects in molecularly proven Kabuki syndrome patients. Am J Med Genet A 173: 2912-2922, 2017.","DOI":"10.1002\/ajmg.a.38417"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lederer D, Grisart B, Digilio MC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 90: 119-124, 2012.","DOI":"10.1016\/j.ajhg.2011.11.021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pad\u011brov\u00e1 J, Holubov\u00e1 A, Simandlov\u00e1 M, et al. Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring. Clin Genet 90: 230-237, 2016.","DOI":"10.1111\/cge.12754"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Banka S, Lederer D, Benoit V, et al. Novel <i>KDM6A<\/i> (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet 87: 252-258, 2015.","DOI":"10.1111\/cge.12363"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. B\u00f6gershausen N, Wollnik B. Unmasking Kabuki syndrome. Clin Genet 83: 201-211, 2013.","DOI":"10.1111\/cge.12051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Merdler-Rabinowicz R, Pode-Shakked B, Vivante A, et al. Kidney and urinary tract findings among patients with Kabuki (make-up) syndrome. Pediatric Nephrol 36: 4009-4012, 2021.","DOI":"10.1007\/s00467-021-05216-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Silva-Andrade N, L\u00f3pez-Ortega K, Gallottini M. Orofacial features and medical profile of eight individuals with Kabuki syndrome. Med Oral Patol Oral Cir Bucal 24: e630-e635, 2019.","DOI":"10.4317\/medoral.22982"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. So PL, Luk HM, Cheung KW, et al. Prenatal phenotype of Kabuki syndrome: a case series and literature review. Prenat Diagn 41: 1089-1100, 2021.","DOI":"10.1002\/pd.5998"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Courcet JB, Faivre L, Michot C, et al. Clinical and molecular spectrum of renal malformations in Kabuki syndrome. J Pediatr 163: 742-746, 2013.","DOI":"10.1016\/j.jpeds.2013.02.032"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mei SC, Pritchard N, Grayton H, Simonicova I, Park SM, Adler AI. Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus. Endocrinol Diabetes Metab Case Rep 2024: 23-0133, 2024.","DOI":"10.1530\/EDM-23-0133"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hamdi Kamel M, Gilmartin B, Mohan P, Hickey DP. Successful long-term outcome of kidney transplantation in a child with Kabuki syndrome. Pediatr Transplant 10: 105-107, 2006.","DOI":"10.1111\/j.1399-3046.2005.00389.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ewart-Toland A, Enns GM, Cox VA, Mohan GC, Rosenthal P, Golabi M. Severe congenital anomalies requiring transplantation in children with Kabuki syndrome. Am J Med Genet 80: 362-367, 1998.","DOI":"10.1002\/(SICI)1096-8628(19981204)80:4<362::AID-AJMG11>3.3.CO;2-N"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nishizaki N, Fujinaga S, Hirano D, et al. Membranoproliferative glomerulonephritis Type 3 associated with Kabuki syndrome. Clin Nephrol 81: 369-373, 2014.","DOI":"10.5414\/CN107464"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Trimarchi H, Barratt J, Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91: 1014-1021, 2017.","DOI":"10.1016\/j.kint.2017.02.003"},{"key":"17","unstructured":"17. Loupy A, Haas M, Roufosse C, et al. The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant 20: 2318-2331, 2020."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oto J, Mano A, Nakataki E, et al. An adult patient with Kabuki syndrome presenting with Henoch-Sch\u00f6nlein purpura complicated with pulmonary hemorrhage. J Anesth 22: 460-463, 2008.","DOI":"10.1007\/s00540-008-0656-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Qu X, Xue F, Liu W, et al. Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: identification of a novel pathogenic mutation. Br J Haematol 205: 347-351, 2024.","DOI":"10.1111\/bjh.19461"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Park E, Kim MS, Noh ES, et al. Multiple endocrine neoplasia type 2 and autoimmune polyendocrine syndromes (type 1 diabetes mellitus and Graves&apos; disease) in a 16-year-old male with Kabuki syndrome. Endocr J 69: 1211-1216, 2022.","DOI":"10.1507\/endocrj.EJ22-0084"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bianchi C, Margot H, Fernandes H, et al. Autoimmune cytopenia and Kabuki syndrome in paediatrics: insights in 11 patients. Br J Haematol 204: 1899-1907, 2024.","DOI":"10.1111\/bjh.19387"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rossini L, Ricci S, Montin D, et al. Immunological aspects of Kabuki syndrome: a retrospective multicenter study of the Italian primary immunodeficiency network (IPINet). J Clin Immunol 44: 105, 2024.","DOI":"10.1007\/s10875-024-01676-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Margot H, Boursier G, Duflos C, et al. Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals. Genet Med 22: 181-188, 2020.","DOI":"10.1038\/s41436-019-0623-x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Giordano P, Lassandro G, Sangerardi M, Faienza MF, Valente F, Martire B. Autoimmune haematological disorders in two Italian children with Kabuki syndrome. Ital J Pediatr 40: 10, 2014.","DOI":"10.1186\/1824-7288-40-10"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ming JE, Russell KL, McDonald-McGinn DM, Zackai EH. Autoimmune disorders in Kabuki syndrome. Am J Med Genet A 132A: 260-262, 2005.","DOI":"10.1002\/ajmg.a.30332"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Peng P, Pan Y, Lu X, et al. Treatment of immune thrombocytopenia with hetrombopag olamine tablets in a Kabuki syndrome patient with new KMT2D mutations. Platelets 34: 2249562, 2023.","DOI":"10.1080\/09537104.2023.2249562"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mushino T, Hiroi T, Yamashita Y, et al. Progressive massive splenomegaly in an adult patient with Kabuki syndrome complicated with immune thrombocytopenic purpura. Intern Med 60: 1927-1933, 2021.","DOI":"10.2169\/internalmedicine.6694-20"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cantoni S, Fattizzo B. Clinical course and management of adult-onset immune-mediated cytopenia associated with Kabuki syndrome. Eur J Intern Med 69: e3-e5, 2019.","DOI":"10.1016\/j.ejim.2019.08.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Leonardi L, Testa A, Feleppa M, et al. Immune dysregulation in Kabuki syndrome: a case report of Evans syndrome and hypogammaglobulinemia. Front Pediatr 11: 1087002, 2023.","DOI":"10.3389\/fped.2023.1087002"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Zannolli R, Buoni S, Macucci F, et al. Kabuki syndrome with trichrome vitiligo, ectodermal defect and hypogammaglobulinemia A and G. Brain Dev 29: 373-376, 2007.","DOI":"10.1016\/j.braindev.2006.11.004"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shah M, Bogucki B, Mavers M, deMello DE, Knutsen A. Cardiac conduction abnormalities and congenital immunodeficiency in a child with Kabuki syndrome: case report. BMC Med Genet 6: 28, 2005.","DOI":"10.1186\/1471-2350-6-28"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hoffman JD, Ciprero KL, Sullivan KE, et al. Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet A 135: 278-281, 2005.","DOI":"10.1002\/ajmg.a.30722"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Gidwani P, Segal E, Shanske A, Driscoll C. Chorea associated with antiphospholipid antibodies in a patient with Kabuki syndrome. Am J Med Genet A 143A: 1338-1341, 2007.","DOI":"10.1002\/ajmg.a.31774"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Suzuki H, Kiryluk K, Novak J, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22: 1795-1803, 2011.","DOI":"10.1681\/ASN.2011050464"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kiryluk K, Novak J, Gharavi AG. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev Med 64: 339-356, 2013.","DOI":"10.1146\/annurev-med-041811-142014"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kiryluk K, Novak J. The genetics and immunobiology of IgA nephropathy. J Clin Invest 124: 2325-2332, 2014.","DOI":"10.1172\/JCI74475"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Magistroni R, D&apos;Agati VD, Appel GB, Kiryluk K. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int 88: 974-989, 2015.","DOI":"10.1038\/ki.2015.252"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Gentile M, Sanchez-Russo L, Riella LV, et al. Immune abnormalities in IgA nephropathy. Clin Kidney J 16: 1059-1070, 2023.","DOI":"10.1093\/ckj\/sfad025"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Oka K, Imai E, Moriyama T, et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 15: 689-695, 2000.","DOI":"10.1093\/ndt\/15.5.689"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Courtney AE, McNamee PT, Nelson WE, Maxwell AP. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Nephrol Dial Transplant 21: 3550-3554, 2006.","DOI":"10.1093\/ndt\/gfl506"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Matsukuma Y, Masutani K, Tsuchimoto A, et al. Effect of steroid pulse therapy on post-transplant immunoglobulin A nephropathy. Nephrology (Carlton) 23 Suppl 2: 10-16, 2018.","DOI":"10.1111\/nep.13272"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Messina M, di Vico MC, Ariaudo C, et al. Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation. J Nephrol 29: 575-583, 2016.","DOI":"10.1007\/s40620-016-0314-5"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hoshino Y, Abe Y, Endo M, et al. Five cases of tonsillectomy and steroid pulse therapy for recurrent immunoglobulin A nephropathy after kidney transplantation. CEN Case Rep 3: 118-122, 2014.","DOI":"10.1007\/s13730-013-0098-6"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Wang Y, Ichimaru N, Kyo M, et al. Beneficial effects of tonsillectomy for mesangial immunoglobulin A (IgA) deposition and clinical outcome in five kidney transplant patients with recurrent IgA nephropathy: case report. Transplant Proc 46: 607-609, 2014.","DOI":"10.1016\/j.transproceed.2013.11.066"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4832-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:24:56Z","timestamp":1757129096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/17\/64_4832-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":44,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4832-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"4832-24"}}